Management of in- and out-of-hospital screening for hepatitis C

Zhou, Jing; Wang, Fa-Da; Li, Lan-Qing; Chen, En‐Qiang

doi:10.3389/fpubh.2022.984810

Cited by 5 publications

(4 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Given the success of the pilot phase and based on international experiences of screening campaign [3][4][5][6][7][8], the MISI Foundation has proposed a PHASE 2.0, introducing a help desk on COVID-19 Vaccines, and Hepatitis facilities. The service is advertised in all pharmacies in the town of Brescia and its province.…”

Section: Previous Projects In the Brescia Area And The Obtained Resultsmentioning

confidence: 99%

Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) Infections among Migrant populations in the Province of Brescia: An Emerging Public Health Issue

2024

Arch Epidemiol

View full text Add to dashboard Cite

The province of Brescia faces a relevant epidemiological situation, with the prevalence of HCV and HBV infection reaching up to 3.0% in some areas. After the COVID-19 pandemic, the increase in HCV-related hepatocellular carcinomas has been overall in migrants. [In Brescia and its province], there is a high number of migrants originating from countries with a high prevalence of viral hepatitis. The epidemiological context has led the MISI Foundation and the non-profit organization "Il Filo della Salute" to undertake a project aimed at identifying infections of HBV and HCV in a settled migrant population from Eastern Europe employed as caregivers. Through the analysis of the most suitable methodologies to engage the target population, which is generally reluctant to undergo medical analyses and tests in the host country, communication strategies have been identified using social web channels and disseminated by influencers to promote the project. The project attracted 350 participants (300 women and 50 men), mainly originating from Moldova.Following pre-test counseling, a self-test for HCVAb was administered, resulting in a positive outcome for 18 (5,1%). Among these, 4.2% tested positive for HCV RNA. In 300 subjects, the HBsAg test was offered, yielding a positive result in 8,3% of cases. All infected individuals were offered linkage to the nearest hepatological or infectious disease care facility based on their residence. The project has allowed the identification of a high number of migrants residing in the province of Brescia infected with HCV or HBV, with percentages consistent with the epidemiology of their country of origin. Within public health projects, it would be crucial to invest in dedicated screening campaigns for the settled migrant population, also considering the role as a caregiver, which is important for both minimizing the risk of transmission and reducing the progression of the infection.

show abstract

Section: Previous Projects In the Brescia Area And The Obtained Resultsmentioning

confidence: 99%

Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) Infections among Migrant populations in the Province of Brescia: An Emerging Public Health Issue

2024

Arch Epidemiol

View full text Add to dashboard Cite

show abstract

“…Author(s) agree that this article remain permanently open access under the terms of the Creative Commons Attribution License 4.0 International License (Zhou et al, 2023).…”

Section: Introductionmentioning

confidence: 89%

Evaluation of viral hepatitis C screening at Institut Pasteur of Cte dIvoire from 2012 to 2022

Viviane,

Daouda,

Moussa

et al. 2023

Afr. J. Biotechnol.

View full text Add to dashboard Cite

The hepatitis C virus (HCV) accounts for 48% of the 1.4 million deaths from viral hepatitis worldwide. The prevalence of HCV was estimated at 5% in Côte d'Ivoire in 2015. The aim is to evaluate screening for the HCV at the Institut Pasteur de Côte d'Ivoire (IPCI) from 2012 to 2022. A retrospective study was carried out to monitor changes in screening for the anti-HCV Ac at the IPCI. The parameters of interest were age, sex and anti-HCV antibody results during the study period. The data collected were recorded in an Excel file and analysed using Rstudio software. According to the results obtained, the positivity rate for males was 5.26% compared with 3.81% for females, and the financial support provided by ROCHE stimulated the screening of a large number of people. The positive rate for viral hepatitis C (4.6%) virtually mirrored the rate of 4.4% obtained in a study of blood donors in Côte d'Ivoire. Finally, this study demonstrated the endemic nature of the HCV in Côte d'Ivoire. Despite financial support to facilitate screening, the seroconversion rate among the population has not shown any increase in the number of people contracting the HCV.

show abstract

“…44,45 By scaling up screening, people who inject drugs can be able to have increased access to harm reduction programs which can lead to reduced risk of new infections. 46 Besides, screening is recognized as a cost-effective measure which makes it instrumental in reducing the overall burden of the disease. 4,47 Therefore, there is a need to increase screening for viral hepatitis as a measure of reducing the rate of infections.…”

Section: Role Of Community Pharmacies In Hepatitis Screeningmentioning

confidence: 99%

Hepatitis Screening in Community Pharmacies as a Measure of Reducing the Rate of Infections

Dave

2024

J. Drug Delivery Ther.

View full text Add to dashboard Cite

The burden of dealing with HBV and HCV still remain despite the progress that has been made in screening, vaccination, and treating the infections. On average, there about 354 million cases of hepatitis globally. Hepatitis has high mortality rates. On average, 1.1 million people lose their lives to the infections each year. Addressing hepatitis requires rigorous measures one of them being increasing screening. Hepatitis infections are identified through screening. As such, screening and taking the right preventative and treatment measures can help to reduce the risk of infections. However, screening is still a challenge. The number of people who screen for hepatitis remains low despite the efforts that have been put in place to increase uptake. The uptake of screening is low because of inadequate access to screening centers. Thus, increasing screening settings can help to increase uptake. Community pharmacies can help to bridge this barrier by making screening more accessible. They are accessible and in close proximity to vulnerable populations, which makes them ideal as screening settings. This review explores the potential of community pharmacies as screening settings for HBV and HCV and whether they can help to reduce the rate of infections. Keywords: screening, hepatitis B, hepatitis C, community pharmacies

show abstract

Management of in- and out-of-hospital screening for hepatitis C

Cited by 5 publications

References 40 publications

Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) Infections among Migrant populations in the Province of Brescia: An Emerging Public Health Issue

Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) Infections among Migrant populations in the Province of Brescia: An Emerging Public Health Issue

Evaluation of viral hepatitis C screening at Institut Pasteur of Cte dIvoire from 2012 to 2022

Hepatitis Screening in Community Pharmacies as a Measure of Reducing the Rate of Infections

Contact Info

Product

Resources

About